Prevalence Rates of Depression, Anxiety, and Suicidal Ideation in Patients with Ovarian cancer: A Systematic Review from 1977 to 2024.
Tong Qiu, Tian Zhang, YiHan Zhang et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review examined observational studies reporting depression, anxiety, and suicidal ideation among people with ovarian cancer, with searches covering studies published through 30 June 2024. Across 31 studies involving 8,315 patients, estimated prevalence was 35% for depression and 37% for anxiety. The review also reported suicidal ideation prevalence of 32% in China. Depression prevalence was highest in Asia and lowest in Oceania; depression and anxiety prevalence rose considerably worldwide after 2000 and then gradually stabilized.
Key findings
- Across 31 studies and 8,315 patients, depression prevalence was 35% and anxiety prevalence was 37%.
- In China, suicidal ideation prevalence among patients with ovarian cancer was 32%.
- Depression prevalence was highest in Asia and lowest in Oceania.
- Depression and anxiety prevalence increased considerably worldwide after 2000 and gradually stabilized thereafter.
Why it matters
The review indicates that depression and anxiety affect more than one-third of the ovarian cancer populations represented in the included studies. These estimates highlight a substantial mental health burden alongside cancer care and point to the need for better evidence on incidence, regional variation, comorbidities, and effective approaches to care.
What to keep in mind
The review included observational studies, and the abstract does not report pooled uncertainty estimates or explain how differences in assessment scales and study populations affected prevalence estimates.